Cost-effectiveness analysis of two treatment strategies for chronic hepatitis C before and after access to direct-acting antivirals in Spain

2017 ◽  
Vol 40 (7) ◽  
pp. 433-446
Author(s):  
Juan Turnes ◽  
Raquel Domínguez-Hernández ◽  
Miguel Ángel Casado
Keyword(s):  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Treatment Strategies ◽  
Cost Effectiveness Analysis ◽  
Direct Acting Antivirals ◽  
Effectiveness Analysis ◽  
Before And After ◽  
Direct Acting

scholarly journals A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan

2019 ◽  
Vol 37 (1) ◽  
pp. 457-476 ◽  
Author(s):  
Isao Kawaguchi ◽  
Kazuaki Chayama ◽  
Yuri Sanchez Gonzalez ◽  
Suchin Virabhak ◽  
Dominic Mitchell ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Cost Effectiveness Analysis ◽  
Direct Acting Antivirals ◽  
Effectiveness Analysis ◽  
Direct Acting

Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis

2017 ◽  
Vol 37 (7) ◽  
pp. 982-994 ◽  
Author(s):  
Antonio Ciaccio ◽  
Paolo A. Cortesi ◽  
Giuseppe Bellelli ◽  
Matteo Rota ◽  
Sara Conti ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Elderly Patients ◽  
Chronic Hepatitis C ◽  
Cost Effectiveness Analysis ◽  
Direct Acting Antivirals ◽  
Effectiveness Analysis ◽  
Direct Acting
Sign in / Sign up

Export Citation Format

Share Document